Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

ATAI Life Sciences BV

ATAI
Current price
1.66 USD -0.02 USD (-1.19%)
Last closed 1.61 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 269 523 648 USD
Yield for 12 month -7.26 %
1Y
3Y
5Y
10Y
15Y
ATAI
21.11.2021 - 28.11.2021

Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its product candidates include COMP360, a proprietary psilocybin which is in Phase 3 program; BPL-003, an intranasal formulation that is in Phase 2a and 2b clinical studies; TRD; VLS-01, an transmucosal film in Phase 1b clinical studies; and ELE-101, a serotonergic psychedelic that is in Phase 1/2a study, for the treatment of treatment resistant depression. The company also develop IBX-210, an intravenous formulation of ibogaine, and DMX-1002, an oral formulation of ibogaine indicated for the treatment of opioid use disorder; EMP-01, an oral formulation of an R-MDMA derivative being developed for the treatment of post-traumatic stress disorder; and EGX-A and EGX-B, psychedelic-like with novel, non-tryptamine structures with differentiated 5-HT receptor pharmacology. In addition, it offers RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator for cognitive impairment associated with schizophrenia; and GRX-917, a deuterated etifoxine for the treatment of generalize anxiety disorder. Further, the company develops PCN-101, a subcutaneous formulation of R-ketamine, as a therapy for psychiatric indications initially focused on TRD; KUR-101, a formulation of deuterated mitragynine for the treatment of OUD; and RLS-01, indicated for treatment resistant depression. ATAI Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany with offices in New York and London. Address: Wallstrasse 16, Berlin, Germany, 10179

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.68 USD

P/E ratio

Dividend Yield

Current Year

+314 000 USD

Last Year

+233 000 USD

Current Quarter

Last Quarter

+18 000 USD

Current Year

-5 000 USD

Last Year

+65 000 USD

Current Quarter

-83 000 USD

Last Quarter

-83 000 USD

Key Figures ATAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -121 952 000 USD
Operating Margin TTM -186483.33 %
PE Ratio
Return On Assets TTM -25.52 %
PEG Ratio
Return On Equity TTM -17.21 %
Wall Street Target Price 10.68 USD
Revenue TTM 314 000 USD
Book Value 1.46 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -52.6 %
Dividend Yield
Gross Profit TTM 233 000 USD
Earnings per share -0.21 USD
Diluted Eps TTM -0.21 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -96.8 %
Profit Margin

Dividend Analytics ATAI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ATAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ATAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 706.1965
Price Sales TTM 1216.114
Enterprise Value EBITDA -6.1068
Price Book MRQ 1.5717

Financials ATAI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ATAI

For 52 weeks

1.03 USD 2.85 USD
50 Day MA 1.96 USD
Shares Short Prior Month 6 306 129
200 Day MA 1.62 USD
Short Ratio 3.07
Shares Short 6 106 172
Short Percent 4.94 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds


S

SX7EEX

14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics